Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Pancreatology
- Vol. 21 (1) , 103-114
Abstract
No abstract availableKeywords
Funding Information
- University of New South Wales
This publication has 60 references indexed in Scilit:
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancersPhysical Biology, 2012
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerBritish Journal of Cancer, 2011
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Role of Pancreatic Stellate Cells in Pancreatic Cancer MetastasisThe American Journal of Pathology, 2010
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary resultJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Assessment of Complications After Pancreatic SurgeryAnnals of Surgery, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Assessment of complications of EUS-guided fine-needle aspirationGastrointestinal Endoscopy, 2001